Home › Funds › Davern Capital Partners, LP › VERA
Davern Capital Partners, LP position in VERA
VERA THERAPEUTICS INC · Health Care
Davern Capital Partners, LP reported holding 628,274 shares of VERA (VERA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$20.3M, representing 3.95% of its reported portfolio and ranking #10 among its reported holdings. Davern Capital Partners, LP has disclosed VERA holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR
How Davern Capital Partners, LP's VERA position evolved
Davern Capital Partners, LP first disclosed a stake in VERA in Q2 2026 at 498,832 shares (US$21.4M). Across 2 filings, Davern Capital Partners, LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 628,274 shares valued at US$20.3M — an increase of 129,442 shares quarter over quarter.. Notable position changes include a 26% increase in Q3 2026 (shares fell 6% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 498.83K | $21.40M | New |
| Q3 2026 | 628.27K | $20.29M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About VERA and 13F data
VERA (VERA THERAPEUTICS INC) is a Health Care company. 39 other funds we track also report a position in VERA — the largest reported positions include Avoro Capital Advisors LLC (US$245.6M), Deep Track Capital, LP (US$171.6M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$168.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding VERA
- Avoro Capital Advisors LLC 5.72M sh · $245.61M · Q2 2026
- Deep Track Capital, LP 4.00M sh · $171.64M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 3.92M sh · $168.05M · Q2 2026
- Kynam Capital Management, LP 2.89M sh · $124.01M · Q2 2026
- Sofinnova Investments, Inc. 2.79M sh · $119.89M · Q2 2026
- Eversept Partners, LP 2.21M sh · $94.95M · Q2 2026
- Logos Global Management LP 2.20M sh · $94.40M · Q2 2026
- Integral Health Asset Management, LLC 1.75M sh · $75.09M · Q2 2026
- Bellevue Group AG 1.71M sh · $73.41M · Q2 2026
- GREAT POINT PARTNERS LLC 600.84K sh · $25.78M · Q2 2026
- BRAIDWELL LP 564.72K sh · $24.23M · Q2 2026
More on Davern Capital Partners, LP
FAQ
How long has Davern Capital Partners, LP held VERA?
Davern Capital Partners, LP has disclosed VERA holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Davern Capital Partners, LP's current position in VERA?
As of Q3 2026, Davern Capital Partners, LP holds 628.27K shares of VERA (VERA THERAPEUTICS INC), valued at $20.29M, representing 3.95% of its reported portfolio and ranking #10.
Has Davern Capital Partners, LP been buying or selling VERA?
In the latest 13F filing (Q3 2026), Davern Capital Partners, LP increased its position in VERA.
Which other funds hold VERA?
Other major institutional holders of VERA include Avoro Capital Advisors LLC, Deep Track Capital, LP, DEERFIELD MANAGEMENT COMPANY, L.P., among 39 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.